Skip to main content

News & Media

Take a look inside our world

Feature stories

COVID-19 Updates and Resources

Creating an Effective Morning Routine with Depression

Antibiotics Aren’t Always the Solution

Teva and the Weizmann Institute of Science enter into collaboration to identify the next generation ...

Teva and Tel Aviv University sign a collaboration agreement for innovative R&D in the fields of canc...

Mount Sinai Publishes New Research Highlighting Novel Method to Identify Patterns Among Patients wit...

Christoph Stoller Appointed as new President of Medicines for Europe

Saving Billions While Fueling Economies: Teva’s First-Ever Global Economic Impact Report

All Feature Stories

All Press Releases

Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Teva Social Media Guidelines

Connect with us

Contacts for Media Inquiries

Kelley Dougherty

Corporate Communications North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Yonatan Beker

Corporate Communications Israel

+972-3-9187869
Yonatan.Beker@tevapharm.com

Smadar Tabenkin-Ezer

Corporate Communications International Markets

+972-3-9062305
Smadar.Tabenkin-Ezer01@teva.co.il

Leslie McGibbon

Corporate Communications Europe

Leslie.Mcgibbon@Tevaeu.com

At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:

Teva Code of Conduct

Supplier Code of Conduct

Social Impact Positions and Policies

All Corporate Governance & Policy Documents

Contact Us
Terms of Use
Data Privacy
PhV Privacy Notice
Teva api
Social Media Guidelines

Follow us

Copyright © 2019-20 Teva Pharmaceutical Industries Ltd.